Caribou Biosciences (CRBU) Return on Sales [ROS] (2020 - 2026)
Caribou Biosciences (CRBU) posted Return on Sales [ROS] of -1690.39% for Q2 2026, up 93.56 percentage points from -1783.95% a year earlier but down 594.02 percentage points from the prior quarter.
Caribou Biosciences (CRBU) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Caribou Biosciences was -1090.90%, up 746.66 percentage points year-over-year; for FY2025, it came in at -1329.37%, up 337.79 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -1037.12 percentage points (FY2020 to FY2025).
- In prior years, Caribou Biosciences' Return on Sales [ROS] was -1667.16% in FY2024 (-1330.53 pp), -336.63% in FY2023 (+431.54 pp), -768.17% in FY2022 (-70.33 pp) and -697.84% in FY2021 (-405.60 pp).
- Quarterly Return on Sales [ROS] has run from a low of -1893.87% in Q1 2024 to a high of -61.84% in Q3 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last four quarters, with an average year-over-year change of -72.81 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2025, with a gain of 1149.72 percentage points; the weakest was Q3 2024, with a drop of 1827.39 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -1096.37% (Q1 2026), -721.97% (Q4 2025) and -1337.58% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Caribou Biosciences | 44.30 Mn | -419.78 Mn | - | -1,720.10% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,720.10% |
| Jun 30, 2026 | -1,690.39% |
| Mar 31, 2026 | -1,096.37% |
| Dec 31, 2025 | -721.97% |
| Sep 30, 2025 | -1,337.58% |
| Jun 30, 2025 | -1,783.95% |
| Mar 31, 2025 | -1,823.76% |
| Dec 31, 2024 | -1,871.69% |
| Sep 30, 2024 | -1,889.23% |
| Jun 30, 2024 | -1,255.80% |
| Mar 31, 2024 | -1,893.87% |
| Dec 31, 2023 | -1,052.33% |
| Sep 30, 2023 | -61.84% |
| Jun 30, 2023 | -875.31% |
| Mar 31, 2023 | -888.52% |
| Dec 31, 2022 | -828.22% |
| Sep 30, 2022 | -803.42% |
| Jun 30, 2022 | -678.22% |
| Mar 31, 2022 | -782.77% |
| Dec 31, 2021 | -797.38% |
Caribou Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();